• Aucun résultat trouvé

Cluster-Driven dynamical arrest in concentrated lysozyme solutions

N/A
N/A
Protected

Academic year: 2022

Partager "Cluster-Driven dynamical arrest in concentrated lysozyme solutions"

Copied!
4
0
0

Texte intégral

(1)

Supporting Information: Cluster-driven dynamical arrest in concentrated lysozyme solutions

Frédéric Cardinaux,

Emanuela Zaccarelli,

,

Anna Stradner,

,

Saskia Bucciarelli,

Bela Farago,

§

Stefan U. Egelhaaf,

Francesco Sciortino,

and Peter

Schurtenberger

#

Department of Physics, University of Fribourg, Fribourg, Switzerland, Dipartimento di Fisica and CNR-ISC, Università di Roma La Sapienza, Roma, Italy, Adolphe Merkle Institute, University of Fribourg, Marly, Switzerland, Institute Laue-Langevin, Grenoble, France, Condensed Matter Physics Laboratory, Heinrich-Heine University, Duesseldorf, Germany,

Dipartimento di Fisica and CNR-ISC, Universit‘a di Roma La Sapienza, Roma, Italy, and Division of Physical Chemistry, Lund University, Lund, Sweden

E-mail: emanuela.zaccarelli@phys.uniroma1.it; Anna.Stradner@unifr.ch

SAXS measurements

We measured the static properties of aqueous solutions of lysozyme obtained under conditions of weak electrostatic screening.1–3 They are determined experimentally by means of small-angle X- ray (SAXS) scattering measurements (see Materials and Methods). To extract the static structur

To whom correspondence should be addressed

University of Fribourg

Universita La Sapienza

University of Fribourg

§Institute Laue-Langevin

Heinrich-Heine University Duesseldorf

Universita La Sapienza

#Lund University

1

(2)

factorSe f f(q)from the measured intensity one has to divide with the form factor of the lysozyme monomer. The resultingSe f f(q)contains information on the correlations between monomers on all length scales, including information on the aggregates formed by the monomers and their spatial correlation.

0.1 1 10 100

I(q) [a.u.]

T=10°C

1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0

Seff(q)

0.01 0.1

q [Å-1]

0.015 0.030 0.059 0.089 0.104 0.118 0.148 0.162 0.179

Figure 1: Top: Scattering intensityI(q)/φ versus scattering vectorqobtained from a systematic SAXS investigation of the concentration dependence of lysozyme solutions atT =10 C in H2O and no added salt. The data has been shifted on the y-axis for better visibility. Bottom: Effective static structure factorsSe f f(q)obtained from the data shown in Top.

To highlight the dependence of the cluster peak position on concentration, we conducted ad- ditional experiments under conditions (10C) where cluster growth is less pronounced. Figure 1 summarizes the results for Se f f(q) obtained by SAXS experiments with lysozyme solutions at 10C in the low salt limit for several values of lysozyme volume fractions. Qualitatively, we ob- serve a systematic decrease of Se f f(q→0) as φ increases, as well as the development of a low qpeak in Se f f(q) that we refer to as the cluster peak (qc). This is followed at larger qby the so- called monomer peak (qm), which is however outside of theq-range covered by our current SAXS measurements.1,2 The position ofqc moves to higherq with increasing φ up to φ 0.08, above which it remains almost constant while its amplitude continuously decreases. Simultaneously, the

2

(3)

amplitude ofqmincreases withφ while its position atqm0.225Å−1was found to be insensitive toφ over the entire range investigated.1

The qualitative behavior ofSe f f(q)provides insight into the type of interactions present among lysozyme particles. First, the decrease ofSe f f(0)with increasingφ is qualitatively consistent with that of a repulsive system. However, the fact that for intermediate and highφ we observe an almost constant peak positionqccontradicts theqn1/3scaling expected for charged systems, wherenis the particle number density. Note that here temperature plays an important role in the modulation ofSe f f(q).2 Typically, an increase in temperature shifts qc to lower values whileqm remains the same but with a slightly smaller amplitude ofSe f f(qm). Finally, the highqpeak atqm0.225 Å−1 suggests strong monomer-monomer correlations at contact resulting from the presence of attractive forces between the particles.

Viscosity measurements

The results for the flow curves on selected samples are shown in the inset of Figure 2. Surprisingly, a shear thinning region is visible for all flow curves and is particularly marked for the lowest measured volume fraction. This effect can be explained with the ability of proteins to unfold and expose their hydrophobic patches at air/water interface and subsequently form weak elastic networks.4 To test this hypothesis, we measured the flow curves of a low viscosity oil where a thin film of the lysozyme solution has been added on the border of our measuring tool. A strong increase of the viscosity at low shear rate is indeed observed and reported in Figure 2. This result demonstrates how this peculiar property of lysozyme at interfaces generates an additional effect for a purely viscous liquid of known viscosity. Figure 2 also shows that the actual zero shear viscosity of the oil can be recovered by an extrapolation of the flow curve at high strain rates. The accuracy of such a procedure strongly depends on the absolute value of the viscosity. We estimate that η0

can be obtained within 25% at lowest φ, whereas an uncertainty of 4% or less can be reached for viscosities about ten times that of the solvent. However, it is important to point out that this procedure is only valid if the non-linear contribution arising from the interfacial network formed

3

(4)

0.01 0.1

[Pa·s]

101 102 103 104 105

[s-1]

0.001 0.01 0.1

[Pa·s]

10 100 1000

[s-1]

. .

Oil / lysozyme fit Oil

0.24 0.218 0.007 buffer

Figure 2: Illustration of the effect produced by the air/solution interface on the measured flow curves of a low viscosity oil with and without a thin layer of lysozyme solution added on the border of the measuring tool. The solid line is a fit to the data that allows to extrapolate the solution zero shear viscosity. Inset: Flow curves measured for lysozyme solutions atT =5Cfor various volume fractions.

by lysozyme decays for shear rates clearly separated from the onset of the non-linear behavior of the bulk solution, which we estimate to occur at much higher values of ˙γ for lysozyme solutions under the current conditions.

References

(1) Stradner, A.; Sedgwick, H.; Cardinaux, F.; Poon, W. C. K.; Egelhaaf, S. U.; Schurtenberger, P.

Nature2004,432, 492–495.

(2) Stradner, A.; Cardinaux, F.; Schurtenberger, P.J. Phys. Chem. B2006,110, 21222–21231.

(3) Cardinaux, F.; Stradner, A.; Schurtenberger, P.; Sciortino, F.; Zaccarelli, E. Europhys. Lett.

2007,77, 48804.

(4) Roberts, S. A.; Kellaway, I. W.; Taylor, K. M. G.; Warburton, B.; Peters, K.Langmuir 2005, 21, 7342–7348.

4

Références

Documents relatifs

16 Negli atti del 73° Congresso Nazionale SIMLII Società Italiana di Medicina del Lavoro ed Igiene Industriale, svoltosi a Roma 1-4 dicembre 2010, è possibile trovare articoli

Scopo del presente lavoro è quello di strutturare un corso formativo teorico- pratico destinato al personale di suppor- to della Asl Roma A per acquisire le conoscenze necessarie

Gli obiettivi terapeutici della medicina scientifi- ca sono spesso indirizzati solamente alla cura della patologia, senza attribuire un senso all’esperienza della malattia intesa

la loro percezione dell’assistenza ricevuta ma anche di resti- tuire loro la dignità nel riconoscimento dei loro bisogni, nel dare testimonianze delle aspettative e delle

Per quanto riguarda invece la valorizza- zione professionale, la Direzione in- fermieristica ha cercato di implementare il coinvolgimento degli infermieri rispetto all’adozione

Quest’anno, poi, Sanit ospiterà numero- se iniziative culturali di interesse socio- sanitario dedicate alla prevenzione e alla promozione dei corretti stili di vita, quali la

L’attivazione a livello distrettuale di un servizio di assistenza infermieristica a livello di comunità, intesa come un insieme di soggetti che condividono aspetti significativi

Infatti, tale documento afferma, al punto 3.1, che: “I pazienti possono aver fiducia che gli Enti Re- golatori avranno dei sistemi che per- metteranno di monitorare, gli standard e